In an attempt to define the role of plasminogen activator in invasiven
ess and differentiation of human melanoma cells, the modulation of the
se parameters was studied in two melanoma clones characterized by mark
ed differences in their basal features, using 12-O-tetradecanoyl-phorb
ol-13-acetate (TPA) and retinoic acid, two differentiation inducers, a
nd doxorubicin, a cytotoxic agent. TPA induced only slight reductions,
whereas retinoic acid and doxorubicin caused an increase in invasiven
ess, enzymatic activity and differentiation in the clone showing low i
nvasivity, low urokinase-type plasminogen activator levels and high di
fferentiation. In contrast, in the clone showing high invasivity, high
urokinase-type plasminogen activator levels and low differentiation i
t was found that: TPA was ineffective; retinoic acid induced a reducti
on of plasminogen activator but no modifications of invasiveness and d
ifferentiation; doxorubicin caused a decrease in invasiveness and plas
minogen activator activity but no modification of morphological featur
es. The different behaviour of the two clones thus could be related to
the basal features of the clones. The results reported here indicate
that in the presence of these drugs the associations between invasiven
ess and urokinase-type plasminogen activator activity and between inva
siveness and differentiation are lost. Drug treatment therefore signif
icantly affected the features of the clone characterized by low biolog
ical aggressiveness (high differentiation, low invasiveness), whereas
the highly aggressive clone did not show a consistent response to drug
treatment.